Company news

Theralase Technologies Inc. news in 2025

Theralase Technologies Inc.'s news releases, calls and decks from 2025, newest first.

View company

Theralase(R) Closes $1.3 M Non-Brokered Private Placement

December 23, 2025

Theralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing

December 12, 2025

Theralase(R) Announces Brokered LIFE Financing to Further Advance its Phase II Non-Muscle Invasive Bladder Cancer Clinical Study

November 24, 2025

Theralase(R) Investor Conference Call Reminder

November 17, 2025

Theralase(R) Releases 3Q2025 Financial Statements

November 10, 2025

Theralase(R) Demonstrates Effectiveness of X-Ray-Activated Drug

November 3, 2025

Independent Research Demonstrates Ruvidar(R) Effective in the Destruction of Herpes Simplex Virus

September 24, 2025

Theralase(R) Extends Warrants

August 29, 2025

Theralase(R) Releases 2Q2025 Financial Statements

August 26, 2025

Theralase(R) Closes Non-Brokered Private Placement

July 28, 2025

Theralase Completes Annual General and Special Meeting

June 12, 2025

Theralase Annual General Meeting

June 5, 2025

Theralase(R) 1Q2025 Financial Statements

May 30, 2025

CORRECTION FROM SOURCE: Theralase to Present Groundbreaking Research at ASTRO 2025

May 29, 2025

Theralase to Present Groundbreaking Research at ASTRO 2025

May 28, 2025

Theralase Provides Corporate Update

May 20, 2025

Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association

May 5, 2025

Theralase Discovers New Mechanism of Action of Lead Drug

April 28, 2025

Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments

April 10, 2025

Ruvidar Demonstrates 7 Year Complete Response

April 7, 2025

Ruvidar Effective in the Treatment of Herpes

March 24, 2025

Theralase(R) Releases 2024 Annual Financial Statements

March 12, 2025

Theralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson's Patients

March 10, 2025

Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin's Lymphoma

February 25, 2025

CORRECTING AND REPLACING: Theralase(R) Demonstrates Effective Treatment of Herpes

February 13, 2025

Theralase(R) Demonstrates Effective Treatment of Herpes

February 12, 2025

Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses

February 10, 2025

Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting

January 27, 2025

Decks in 2025